ArticleActa dermato-venereologica2025
Prevalence of Central Sensitization in Notalgia Paresthetica Patients and its Association with Vertebral Degeneration: A Cross-sectional Study.
Article in Acta dermato-venereologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Commentary on "Prevalence of Central Sensitization in Notalgia Paresthetica Patients and Its Association with Vertebral Degeneration: A Cross-sectional Study".Acta dermato-venereologica · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Notalgia paresthetica (NP) is a sensory neuropathy characterized by itching and hyperpigmentation, typically around the scapular region. This study aimed to investigate the relationships between clinical findings, radiological features, and central sensitization (CS) in NP patients. This cross-sectional study included 45 NP patients and 45 age- and gender-matched healthy controls. Neuropathic symptoms were assessed using the painDETECT questionnaire (PD-Q), while CS symptoms were evaluated with the Central Sensitization Inventory (CSI). Pain and pruritus severity were evaluated using a Visual Analogue Scale (VAS). Cervical-thoracic vertebral pathologies were examined via 2-view X-rays. Vertebral degeneration was observed in 75.5% of NP patients, which was significantly higher than in controls (p = 0.001). CS was present in 48.9% of NP patients, also significantly higher than in the control group (p = 0.020). A higher rate of prior fibromyalgia diagnosis, based on CSI-B responses, was found in NP patients (p = 0.05). NP patients with CS had significantly higher VAS pain scores (p < 0.001), PD-Q scores (p = 0.005), and vertebral degeneration rates (p = 0.001) compared with those without CS. Additionally, 63.6% of NP patients with CS had lesions in multiple vertebral regions (p = 0.002). CS is common in NP patients, especially in those with vertebral degeneration. Multidisciplinary evaluation considering CS status may improve management of NP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.